Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunityBio converts from Immunomedics -- Ignore unavailable to you. Want to Upgrade?

To: End2War who wrote (810)	1/13/2025 3:03:38 PM
From: galt	1 Recommendation Recommended By Huggenberg Respond to of 1230

My investments, (not bets), as regards biotechs, are mainly based on the science, NOT the person. I've spent years investing in biotechs, many with good results and many failures. RARELY, if ever, were my decisions based on the person. Take IMMU, for example. And yes, based on the approvals IBRX has received, I do feel that we are very safe with the current price point of the shares. Very little downside and very great upside, at this point. I do have other investments that are based very much on the person, but rarely if ever in biotechs. Good luck to you with your deep understandings of PSS and those like him. Thanks for your comments, and, of course mine are just that.... IMO.